PlainRecalls
FDA Drug Low Class III Terminated

Cyproheptadine Hydrochloride Syrup, Oral Solution USP, 2 mg/5 mL, packaged in an amber glass 473 mL (one pint) bottle with child-resistant screw closure, Rx only, Distributed by: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Manufactured by: Lyne Laboratories, Inc., Brockton, MA 02301, NDC 64980-0504-48

Reported: July 13, 2016 Initiated: June 7, 2016 #D-1062-2016

Product Description

Cyproheptadine Hydrochloride Syrup, Oral Solution USP, 2 mg/5 mL, packaged in an amber glass 473 mL (one pint) bottle with child-resistant screw closure, Rx only, Distributed by: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Manufactured by: Lyne Laboratories, Inc., Brockton, MA 02301, NDC 64980-0504-48

Reason for Recall

Subpotency: product assayed and found OOS for cyproheptadine

Details

Recalling Firm
Lyne Laboratories, Inc.
Units Affected
12,215 Bottles shipped to Rising Pharmaceuticals
Distribution
NJ
Location
Brockton, MA

Frequently Asked Questions

What product was recalled?
Cyproheptadine Hydrochloride Syrup, Oral Solution USP, 2 mg/5 mL, packaged in an amber glass 473 mL (one pint) bottle with child-resistant screw closure, Rx only, Distributed by: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Manufactured by: Lyne Laboratories, Inc., Brockton, MA 02301, NDC 64980-0504-48. Recalled by Lyne Laboratories, Inc.. Units affected: 12,215 Bottles shipped to Rising Pharmaceuticals.
Why was this product recalled?
Subpotency: product assayed and found OOS for cyproheptadine
Which agency issued this recall?
This recall was issued by the FDA Drug on July 13, 2016. Severity: Low. Recall number: D-1062-2016.